Analysis

IPOs Still Face Uncertainty Even As Government Reopens

Law360 (January 28, 2019, 8:47 PM EST) -- Even with the U.S. Securities and Exchange Commission back at full staff now that the government shutdown is at least temporarily over, only a narrow sliver of companies with time-sensitive plans to complete initial public offerings are likely to move forward on deals in the coming days.

Lowenstein Sandler LLP partner Steve Skolnick said he is advising underwriters on two small IPOs from life sciences companies that hope to take advantage of a brief market window in the next two weeks or so. Lawyers point out that biotechnology firms, which often lack revenue in their early stages, have a more urgent...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS